KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Current Deferred Revenue: 2009-2024

Historic Current Deferred Revenue for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $33.8 million.

  • Idexx Laboratories' Current Deferred Revenue fell 7.13% to $35.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.7 million, marking a year-over-year decrease of 7.13%. This contributed to the annual value of $33.8 million for FY2024, which is 9.13% down from last year.
  • As of FY2024, Idexx Laboratories' Current Deferred Revenue stood at $33.8 million, which was down 9.13% from $37.2 million recorded in FY2023.
  • Idexx Laboratories' Current Deferred Revenue's 5-year high stood at $42.6 million during FY2020, with a 5-year trough of $33.8 million in FY2024.
  • Over the past 3 years, Idexx Laboratories' median Current Deferred Revenue value was $37.2 million (recorded in 2023), while the average stood at $36.3 million.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first grew by 2.67% in 2020, then decreased by 9.13% in 2024.
  • Over the past 5 years, Idexx Laboratories' Current Deferred Revenue (Yearly) stood at $42.6 million in 2020, then fell by 5.95% to $40.0 million in 2021, then decreased by 5.24% to $37.9 million in 2022, then dropped by 1.96% to $37.2 million in 2023, then decreased by 9.13% to $33.8 million in 2024.